PA

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Fiehn C – Methotrexate (MTX) is a folate inhibitor which has gained a major role in the treatment of rheumatoid arthritis (RA). MTX is not only the disease modifying anti–rheumatic drug of first choice, a large number of clinical trials moreover show that biologic drugs should be combined with MTX in order to obtain optimal therapeutic efficacy. The goal to further develop the most successful principle of folate inhibition for the treatment of rheumatic diseases seems to be feasible.

Today in Clinical Pharmacology...keeping you current

ACC, AHA Update Guidelines for Beta Blockers
American Family Physician, 12/17/09

Pharmacist and physician collaborative prescribing: For medication renewals within a primary health centre
Canadian Family Physician, 12/17/09

Taking the stress out of managing gout
Canadian Family Physician, 12/17/09

Today in Rheumatology...keeping you current

Taking the stress out of managing gout
Canadian Family Physician, 12/17/09

Phytalgic(R), a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial
Arthritis Research & Therapy, 12/17/09

Elevated Circulating and Synovial Fluid Endoglin Are Associated with Primary Knee Osteoarthritis Severity
Archives of Medical Research, 12/17/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address